802
Participants
Start Date
April 30, 2024
Primary Completion Date
March 31, 2029
Study Completion Date
March 31, 2029
Ampicillin
Intravenous Ampicillin
Gentamicin
Intravenous Gentamicin
Placebo
Intravenous Normal Saline
Columbia University, New York
Westchester Medical Center, Valhalla
State University of New York Downstate, Brooklyn
University of Rochester, Rochester
Magee-Womens Hospital, Pittsburgh
The University of Pittsburgh Medical Center, Pittsburgh
The Children's Hospital of Philadelphia, Philadelphia
Jefferson Medical College of Thomas Jefferson University, Philadelphia
University of South Florida, Tampa
University of Louisville, Louisville
University of Texas Health Science Center at San Antonio, San Antonio
Sharp Mary Birch Hospital for Women & Newborns, San Diego
Yale University, New Haven
The Pennsylvania State University, Hershey
Sinai Health System, Toronto
University of Pittsburgh
OTHER
Morgan Stanley Children's Hospital
OTHER
University of Louisville
OTHER
Sharp Mary Birch Hospital for Women & Newborns
OTHER
Children's Hospital of Philadelphia
OTHER
Jefferson Medical College of Thomas Jefferson University
OTHER
University of South Florida
OTHER
Westchester Medical Center
OTHER
Yale University
OTHER
The University of Texas Health Science Center at San Antonio
OTHER
Penn State University
OTHER
State University of New York - Downstate Medical Center
OTHER
Mount Sinai Hospital, Canada
OTHER
Sharp HealthCare
OTHER